Clinical Trial Update: An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada

View source ↗

Summary

An observational study in Canada assessed real-world use of canagliflozin for type 2 diabetes mellitus; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)

Snippet

Sponsor: Janssen Inc. | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED